Abstract
Correlation of Mutational Profile and Response in Patients with Polycythemia Vera and Essential Thrombocythemia Treated with Pegylated Interferon Alfa 2a As Part of a Prospective Phase II Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have